1. Tegaserod inhibits the serotonin transporter SERT. Ismair MG, Kullak-Ublick GA, Blakely RD, Fried M, Vavricka SR (2007) Digestion 75(2-3): 90-5
    › Primary publication · 17510552 (PubMed)
  2. Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots. Tomlinson ID, Warnerment MR, Mason JN, Vergne MJ, Hercules DM, Blakely RD, Rosenthal SJ (2007) Bioorg Med Chem Lett 17(20): 5656-60
    › Primary publication · 17766114 (PubMed)
  3. Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors. Zhu CB, Steiner JA, Munn JL, Daws LC, Hewlett WA, Blakely RD (2007) J Pharmacol Exp Ther 322(1): 332-40
    › Primary publication · 17460150 (PubMed)
  4. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A (2007) PLoS Biol 5(10): e274
    › Primary publication · 17941718 (PubMed) · PMC2020502 (PubMed Central)
  5. Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter. Mason JN, Deecher DC, Richmond RL, Stack G, Mahaney PE, Trybulski E, Winneker RC, Blakely RD (2007) J Pharmacol Exp Ther 323(2): 720-9
    › Primary publication · 17673606 (PubMed)
  6. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, Levey AI, Blakely RD (2007) Genes Brain Behav 6(5): 411-24
    › Primary publication · 17010154 (PubMed)
  7. Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A. Sung U, Blakely RD (2007) Mol Cell Neurosci 34(2): 251-60
    › Primary publication · 17188889 (PubMed) · PMC1847414 (PubMed Central)
  8. Bound to be different: neurotransmitter transporters meet their bacterial cousins. Henry LK, Meiler J, Blakely RD (2007) Mol Interv 7(6): 306-9
    › Primary publication · 18199851 (PubMed)
  9. An automated fluorescence-based method for continuous assay of PP2A activity. Wegner AM, McConnell JL, Blakely RD, Wadzinski BE (2007) Methods Mol Biol : 61-9
    › Primary publication · 17200554 (PubMed)
  10. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Dipace C, Sung U, Binda F, Blakely RD, Galli A (2007) Mol Pharmacol 71(1): 230-9
    › Primary publication · 17032905 (PubMed)